Value Investing in Special Situations and Esoteric Opportunities - Episode Hero Image

Value Investing in Special Situations and Esoteric Opportunities

Original Title:

TL;DR

  • Activist investing in small companies is challenging due to high fixed costs for legal and advisory services, making small-cap companies a de facto corporate defense against shareholder engagement.
  • Smallness acts as a corporate defense because activist expenses do not scale down proportionally with smaller potential gains, creating a "hopeless situation" for activists targeting micro-cap firms.
  • Broken biotech companies with failed research present opportunities for activists to buy assets at a discount to NAV, but face significant friction from management and industry specialists resistant to liquidation.
  • Activist investors must consider selling their entire position as an alternative to direct intervention, as activism is a crude tool and control of a board or management is crucial for success.
  • The gamification of trading apps blurs the lines between investing and gambling, potentially distancing individuals from the concept of long-term business ownership and value creation.
  • AI's potential for high computational costs and its ability to provide obsequious, personalized responses could create a "dark future" by diminishing genuine human interaction and critical thinking.
  • Event-driven investing in special situations, particularly those involving regulatory issues or corporate changes, allows for opportunities where traditional valuation methods may not apply.

Deep Dive

Chris DeMuth Jr. advocates for a value investing approach focused on special situations and event-driven opportunities, often with a regulatory or policy component. He observes that the current US equity market, particularly mega-cap tech, appears fully priced, leading him to seek opportunities internationally, in smaller caps, and in "esoteric" situations involving litigation or corporate changes. This strategic shift away from broad US equity exposure is driven by a desire to find undervalued assets in less-followed or misunderstood companies.

DeMuth highlights two specific investment ideas: Willis Lease (WLFC) and Golden Entertainment (GDEN). Willis Lease, an aerospace leasing company, is seen as significantly undervalued due to its valuable engine portfolio and recent joint ventures that could transform it into an asset manager, potentially converging its market cap with larger peers like FTAI Aviation. The market, DeMuth argues, has not fully appreciated these JVs' potential to increase earnings and unlock the hidden value of the company's engine inventory. California First Leasing (CFNB) is another company trading at a discount to its Net Asset Value (NAV), with management attempting to delist to avoid regulatory compliance costs under the 1940 Act. DeMuth believes this move could be defeated, leading to a potential revaluation closer to NAV. Regarding Golden Entertainment (GDEN), DeMuth opposes a proposed deal where management is acquiring the operating company at a low multiple while commingling it with a sale-leaseback of real estate. He argues this structure undervalues the core operating business, suggesting shareholders should vote against it.

The implications of DeMuth's strategy and observations are significant. His focus on NAV and asset value, particularly in niche sectors like aerospace leasing or financial services (CFNB), suggests that specialized knowledge and a deep dive into balance sheets can uncover substantial mispricings. The potential for Willis Lease to evolve into an asset manager implies a shift from traditional leasing to a more scalable, fee-based model, which could command higher valuations. Similarly, the situation with California First Leasing underscores how regulatory burdens can create opportunities for value investors if those burdens can be circumvented or eliminated. His opposition to the Golden Entertainment deal highlights the critical role of activist investors in scrutinizing transaction structures to ensure fair value for all shareholders, particularly when management interests may diverge from theirs. DeMuth's broader commentary on AI suggests that while the technology is transformative, its current market pricing may be overly influenced by hype, and true value may lie in less obvious applications, such as Core Scientific's transition to data centers, rather than widely publicized trends. He emphasizes that human interaction and community will likely become more valuable as AI automates mundane tasks and potentially creates a more personalized, yet potentially isolating, digital experience.

Action Items

  • Analyze Willis Lease (WLFC) partnerships: Quantify potential earnings growth and asset value realization from new joint ventures within 2 weeks.
  • Audit California First Leasing (CFNB) NAV discount: Calculate current discount to NAV and projected value increase if 1940 Act compliance fails.
  • Evaluate Golden Entertainment (GDEN) deal structure: Assess fiduciary duty compliance and potential for shareholder value maximization by opposing the current transaction.
  • Track 3-5 "broken biotech" companies: Monitor cash burn rates and potential liquidation timelines to identify opportunities for NAV-based investment.
  • Measure activist engagement cost-benefit: For 2-3 past activist situations, estimate legal and advisory expenses versus realized shareholder value gains.

Key Quotes

"I kind of come from the value tradition. I'm a value investor, but more specifically, I look at special situations and event-driven opportunities, usually with some kind of policy bent."

Chris DeMuth Jr. explains that his investment approach is rooted in value investing but is more specialized. He focuses on "special situations" and "event-driven opportunities," often influenced by policy or regulatory factors, indicating a nuanced strategy beyond traditional value metrics.


"So I kind of have residual inventory, kind of topics tied to the US, and a lot of the things I think about are here. I live in the US, but equities are pretty fully valued, especially mega-cap tech. I'm shy about saying that because they looked kind of expensive to me and then more expensive and more expensive and have done really, really well through today. But I'm not eager for lots of kind of long US equity exposure."

Chris DeMuth Jr. expresses caution regarding the current US equity market, particularly mega-cap tech stocks, which he perceives as fully valued. He indicates a preference for international markets and smaller-cap companies that have not participated in the recent tech boom, suggesting a search for opportunities outside of mainstream, highly-valued US equities.


"But the thing that I would point out is a company that was and is very shareholder-facing, well-regarded, and I'd say well-understood by the market is FTAI Aviation. FTAI, no position in it, but I've followed it really carefully, and it has a, you know, $24, $25 billion market cap, so much, much bigger than Willis. But I think Willis's model, they're really changing. They've announced a number of JVs in the past month that I don't think the market's realized how much this could transform their business."

Chris DeMuth Jr. contrasts Willis Lease (WLFC) with FTAI Aviation, noting that FTAI is a larger, well-understood company in the same sector. He highlights that the market has not yet fully appreciated the transformative potential of Willis Lease's recent joint ventures (JVs), suggesting an undervaluation of WLFC due to its changing business model.


"On my way in, and this is something, you know, I've been for a very long time at this point, I'm very focused on assets. I'm very focused on paying a big at the time discount to NAV, especially where it's a plausible business, earning okay. And I'm just looking at an NAV that is that uses historical appraisals and a market where the market value had raced way ahead, and the market value is really transparent."

Chris DeMuth Jr. emphasizes his focus on net asset value (NAV) as a key metric, particularly when investing in companies trading at a significant discount to their NAV. He explains that this approach is viable when the underlying business is sound and earning a reasonable profit, and where the market value of assets is transparent and has outpaced historical appraisals.


"I would say that one of the things that I've learned is how much smallness is a corporate defense. And smallness is a corporate defense because my expenses as a shareholder don't scale down that well. I mean, I normally get my money back if I win, but the problem or situation is lawyers, advisors, and so forth. There's a kind of unitary cost to that that if I can make $100 million isn't that different than if I can make a million dollars."

Chris DeMuth Jr. identifies "smallness" as a corporate defense mechanism, explaining that the costs associated with shareholder activism do not decrease proportionally with smaller investment gains. He notes that the fixed costs for lawyers and advisors remain substantial, making it challenging to achieve a profitable outcome when dealing with smaller companies or smaller potential gains.


"I think that the least interesting drug is alcohol. I think its social acceptance is just a kind of a cultural historical artifact relative to the downside. You know, hangovers have to be one of the common most underrated symptoms of a serious health thing, right? Like if you walked up to somebody and you punched them in the face with the precise force equaling to a bad hangover the next day, you'd go to jail, and anybody would say like, of course you would, like you ruined a whole day of something."

Chris DeMuth Jr. expresses a critical view of alcohol's social acceptance, contrasting its perceived mildness with the severe health consequences of hangovers. He uses a vivid analogy to illustrate that the physical impact of a hangover, if inflicted externally, would be considered assault, suggesting that society underestimates alcohol's detrimental effects due to its cultural normalization.

Resources

External Resources

Books

  • "Sifting the World" by Chris DeMuth Jr. - Mentioned as the name of an investing group run by the guest.

Articles & Papers

  • "Quote the Raven" by Chris Irons - Mentioned as a publication the guest follows regarding psychedelics.

People

  • Chris DeMuth Jr. - Guest, investor, and operator of the "Sifting the World" investing group.
  • Chris Irons - Mentioned as a friend and writer of "Quote the Raven" who follows psychedelic investments.

Organizations & Institutions

  • Seeking Alpha - Platform where Chris DeMuth Jr. runs his investing group and where his investment cases are made.

Other Resources

  • Special Situations and Event Driven Opportunity - The primary focus of Chris DeMuth Jr.'s investment strategy.
  • Value Tradition - The investment philosophy Chris DeMuth Jr. adheres to.
  • 1940 Act - Legislation that impacts the compliance and transparency requirements for certain investment companies, specifically mentioned in relation to California First Leasing.
  • AI (Artificial Intelligence) - Discussed as a transformative technology with potential applications in data centers and healthcare, but also with potential downsides related to human interaction and job displacement.
  • Psychedelics - Mentioned as a promising area for investment and therapeutic potential, with a comparison to marijuana and alcohol in terms of health risks.
  • Cannabis - Mentioned as a promising area from a health and medicinal perspective.
  • Alcohol - Discussed in comparison to marijuana and psychedelics, noting its significant health risks despite social acceptance.

---
Handpicked links, AI-assisted summaries. Human judgment, machine efficiency.
This content is a personally curated review and synopsis derived from the original podcast episode.